Covid, 140 cases: 18 in the Lecce area. Puglia In the White Zone From 14. Minelli On The Astrazeneca Case: “Customizing Vaccination”

Covid, 140 cases: 18 in the Lecce area. Puglia In the White Zone From 14. Minelli On The Astrazeneca Case: “Customizing Vaccination”
Covid, 140 cases: 18 in the Lecce area. Puglia In the White Zone From 14. Minelli On The Astrazeneca Case: “Customizing Vaccination”

PUGLIA – The contagion curve is decreasing more and more: the Apulians hospitalized because of the covid are 294. On June 14, 2021, Puglia passes into the white zone: there was some doubt about 3 indicators, compared to the total 21, but everything went well. “We firmly believe in the science that has offered us these vaccines, and I thank the Italians: we are almost 1 in 2 Italians who received the first dose but we still have to accelerate” – said the Minister of Health. Roberto Speranza, in the press conference to update the vaccination campaign. Then came the confirmation for the new white zones that will start on Monday: “Emilia Romagna, Lazio, Piedmont, Puglia and the Autonomous Province of Trento will go to the white zone, I will sign an ordinance. We are in the right direction and in the right direction. We now have an incidence of 26 cases and this places us as the second best country in the EU ”.


Sponsored Link

We owe this exit from the pandemic tunnel above all to vaccines, not only to the summer that makes us spend more time outdoors. Astrazeneca (which today is called Vaxzevria), however, it continues to be at the center of a debate full of doubts and perplexities. It is recommended for the over 60s and the regions have insisted on administering it to younger teaching staff and graduates. Why choose to risk so much? “The improvement of the epidemiological situation and the greater availability of vaccines in Mrna, taking into account the principle of maximum caution, allow us to ‘strengthen the recommendation’ to use the Astrazeneca vaccine for people over 60 ‘”- Minister Speranza declared today, after confirmation by the Committee in charge.

Let us remember that Astrazeneca immediately seemed an inconvenient vaccine in terms of combating covid, because it was not effective against the South African variant (it was returned by the Africans). Then, the cases of thrombosis arrived in Italy. Camilla Canepa, the student vaccinated last May 25 at the open day, lost her life: she suffered from familial autoimmune thrombocytopenia and was taking double hormone therapy. Investigators are trying to understand if the two pathologies were indicated in the card delivered before the administration.

Sponsored Link


We asked Dr. Mauro Minelli, immunologist among the coordinators of the Foundation for Personalized Medicine, an opinion on the right approach to adopt. Personalized medicine today is applied by the greatest luminaries with success in the oncology field: the philosophy behind it is to study the single individual and then calibrate the best possible therapy on his specific organism. We must refrain from administering Astrazeneca to the youngest, or not?

«I have always believed – and we at the Foundation for Personalized Medicine have made it a cornerstone of our activities – in the indispensable principle of proceeding, even in the dynamics of vaccination, according to logics that are as “precise” as possible. As if to say that vaccination cannot be the mere execution of a “puncture”After having entrusted the vaccinator with the task of completing a questionnaire. Vaccination is not just a summarily quantitative issue (of the type “the more we do it, the better we are”), all the more in the face of alert repeatedly reiterated, as in the case of viral vector vaccines (AstraZeneca or Johnson & Johnson), and repeatedly underestimated, when not completely ignored. The correct interpretation of the “risk-benefit” concept passes through knowledge and tests useful to avoid toxicity that, perhaps, derive from the sum of side effects in patients forced to take more drugs, or useful to define whether or not to administer a drug based on the real clinical history collected by the patient. All this will make it possible to overcome, even in anti-vaccination practicesCovid, the aberrant practice of trial and error, or the alchemical synopsis condensed in undifferentiated thought: “TI administer this product and let’s see if it is well tolerated … otherwise we suspend it or, maybe, we change it“. I challenge anyone to deny that this is still today the operational base on which current medicine continues to be largely founded, with consequent suffering for the patient and unnecessary costs for the health system. Suffering and absolutely avoidable costs if only predictive or at least exploratory methods were implemented (the famous and never correctly applied “narrative medicine”) capable of identifying, even before administration, which is the right active ingredient and, therefore, what it can be used more profitably by every single person well beyond the widespread conception of “let’s see if it tolerates it” It would be rhetorical and, as such, this discourse would be superfluous if, with regard to anti-Covid vaccination, we could not have other products that they are not only those with an adenoviral vector, which are strongly “immunogenic” and, therefore, capable of evoking or, if anything, detecting immune reactions in the recipient organism. But being able to use “other” and documentally less aggressive vaccines, it becomes an unnecessarily risky exercise to proceed with vaccination with logic merely quantitative. The real effectiveness of the vaccination campaign (and the skill of those who organize it) they are not only in having indiscriminately vaccinated and in a predefined time the largest possible number of people, of any age and in whatever condition they are, but having prepared, with doctors, ideal conditions to associate, through careful customization procedures, the most profitable and safest prevention paths for each individual, whether they are healthy or sick».


Today’s epidemiological bulletin, Friday 11 June 2021 in Puglia, records 5,684 tests for Covid-19 coronavirus infection and highlights 140 positive cases: 38 in the province of Bari, 22 in the province of Brindisi, 9 in the province of BAT, 26 in the province of Foggia, 18 in the province of Lecce, 26 in the province of Taranto, 1 case of resident outside the region.

7 deaths were recorded: 5 in the BAT province, 2 in the province of Lecce.

Since the beginning of the emergency, 2,561,176 tests have been carried out.

231,088 patients recovered.

14,347 are currently positive cases.

The total of positive Covid cases in Puglia is 252,020, divided as follows:

94,872 in the Province of Bari;

25,467 in the Province of Bat;

19,565 in the Province of Brindisi;

44,999 in the Province of Foggia;

26,749 in the Province of Lecce;

39,199 in the Province of Taranto;

802 attributed to residents outside the region;

367 province of residence not known.

Sponsored Link

PREV From 12 June the calls for the under 60s will not be made with Astrazeneca
NEXT Car market Italy 2021: in May registrations drop by 27.9% on 2019